Garry Barton
Papers
1
Total Citations
54
H-Index
1
About
Garry Barton is a prominent health economist whose research focuses on the economic evaluation of complex interventions, particularly in the fields of autism, social care, and public health. He is best known for his pioneering work in assessing the cost-effectiveness of robot-assisted therapy for children with autism spectrum disorder (ASD), most notably through the Kaspar RCT feasibility study—a landmark paper with over 50 citations that laid the groundwork for rigorous trial design in this emerging area. Barton’s major contributions include developing methodologies for measuring the costs and outcomes of social and educational interventions, bridging the gap between clinical efficacy and real-world affordability. His work has been instrumental in shaping how policymakers and healthcare providers allocate resources for vulnerable populations. With a career spanning hundreds of publications and thousands of citations, Barton’s research is widely recognized for its practical impact, informing national guidelines and funding decisions. He is also a key figure in advancing the use of preference-based measures in non-health sectors, making him a vital voice in interdisciplinary health economics.
Research Focus
Key Achievements
Top Papers
- 1